Korea Kolmar on major pharmaceutical business.

Published: 2005-05-17 07:00:00

Updated: 2005-05-17 07:00:00

Korea Kolmar Inc. has engaged in a major pharmaceutical business after establishing their own sales networks, KGMP facilities and other R&D infrastructures for the toll and generic drug manufacture last year.

Korea Kolmar plans to develope a toll manufacturing, skin care products and generic d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK